FDA Inspection 1248187 — Shady Grove Fertility Reproductive Science Center
The FDA completed an inspection of Shady Grove Fertility Reproductive Science Center on August 15, 2024 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Washington, DC (United States)